← All trials
NCT05085834
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 22, 2020
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2022
- First posted
- Oct 20, 2021
- Last posted
- Dec 2, 2021
- Enrollment
- 93
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Case Western Reserve UniversityLead sponsor
- Case Western Reserve UniversityCollaborator
- Case Western Reserve UniversityOverall official - principal investigator
- Case Western Reserve UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.